KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Work In Process: 2010-2012

Historic Work In Process for Jazz Pharmaceuticals (JAZZ) over the last 1 years, with Sep 2012 value amounting to $2.2 million.

  • Jazz Pharmaceuticals' Work In Process was N/A to $2.2 million in Q3 2012 from the same period last year, while for Sep 2012 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $524,000 for FY2011, which is 25.67% down from last year.
  • Jazz Pharmaceuticals' Work In Process amounted to $2.2 million in Q3 2012, which was down 63.95% from $6.1 million recorded in Q2 2012.
  • Jazz Pharmaceuticals' 5-year Work In Process high stood at $6.1 million for Q2 2012, and its period low was $524,000 during Q4 2011.
  • In the last 3 years, Jazz Pharmaceuticals' Work In Process had a median value of $1.3 million in 2012 and averaged $2.2 million.
  • Data for Jazz Pharmaceuticals' Work In Process shows a maximum YoY dropped of 25.67% (in 2011) over the last 5 years.
  • Quarterly analysis of 3 years shows Jazz Pharmaceuticals' Work In Process stood at $705,000 in 2010, then fell by 25.67% to $524,000 in 2011, then reached $2.2 million in 2012.
  • Its Work In Process stands at $2.2 million for Q3 2012, versus $6.1 million for Q2 2012 and $1.3 million for Q1 2012.